These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34535319)

  • 1. Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy.
    Kim DY; Kang YM; Cho HK; Park SJ; Lee MH; Lee YJ; Kang HM
    Vaccine; 2021 Oct; 39(42):6201-6205. PubMed ID: 34535319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live recombinant Newcastle disease virus vectored vaccine expressing the haemagglutinin of H9N2 avian influenza virus suppresses viral replication in chickens.
    Lee J; Cho AY; Kim DH; Lee JB; Park SY; Choi IS; Lee SW; Song CS
    Avian Pathol; 2023 Apr; 52(2):100-107. PubMed ID: 36377478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of SPF Chickens by H9N2 Y439 and G1 Lineage Vaccine against Homologous and Heterologous Viruses.
    Cho HK; Kang YM; Sagong M; Kim J; Kim H; An S; Lee YJ; Kang HM
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice.
    Park SJ; Kang YM; Cho HK; Kim DY; Kim S; Bae Y; Kim J; Kim G; Lee YJ; Kang HM
    Vaccine; 2021 Oct; 39(42):6213-6220. PubMed ID: 34556363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of Chickens against H9N2 Avian Influenza Isolates with a Live Vector Vaccine Expressing Influenza Hemagglutinin Gene Derived from Y280 Avian Influenza Virus.
    Zhang JF; Kim SW; Shang K; Park JY; Choi YR; Jang HK; Wei B; Kang M; Cha SY
    Animals (Basel); 2024 Mar; 14(6):. PubMed ID: 38539970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering an Optimal Y280-Lineage H9N2 Vaccine Strain by Tuning PB2 Activity.
    An SH; Hong SM; Song JH; Son SE; Lee CY; Choi KS; Kwon HJ
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
    Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X
    Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.
    Dabaghian M; Latify AM; Tebianian M; Nili H; Ranjbar AR; Mirjalili A; Mohammadi M; Banihashemi R; Ebrahimi SM
    Vet Microbiol; 2014 Nov; 174(1-2):116-26. PubMed ID: 25293397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
    Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
    Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza virus-like particles harboring H9N2 HA and NA proteins induce a protective immune response in chicken.
    Li X; Ju H; Liu J; Yang D; Qi X; Yang X; Qiu Y; Zheng J; Ge F; Zhou J
    Influenza Other Respir Viruses; 2017 Nov; 11(6):518-524. PubMed ID: 28752641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity of H9N2 low pathogenic avian influenza viruses of different lineages isolated from live bird markets tested in three animal models: SPF chickens, Korean native chickens, and ducks.
    Kye SJ; Park MJ; Kim NY; Lee YN; Heo GB; Baek YK; Shin JI; Lee MH; Lee YJ
    Poult Sci; 2021 Sep; 100(9):101318. PubMed ID: 34284181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of field cases of Y280-like LPAI H9N2 strains in South Korean poultry farms: pathological findings and genetic characterization.
    Lai VD; Kim JW; Choi YY; Kim JJ; So HH; Mo J
    Avian Pathol; 2021 Aug; 50(4):327-338. PubMed ID: 34013789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
    Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
    Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
    Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
    Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
    Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
    Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
    Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea.
    Song JM; Lee YJ; Jeong OM; Kang HM; Kim HR; Kwon JH; Kim JH; Seong BL; Kim YJ
    Vet Microbiol; 2008 Aug; 130(3-4):268-76. PubMed ID: 18374520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
    Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
    Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.